Q32 Bio (QTTB) Retained Earnings (2017 - 2026)

Q32 Bio's Retained Earnings history runs 10 years deep, the most recent figure standing at -$212.6 million for Q1 2026.

• In Q1 2026, Retained Earnings rose 13.51% year-over-year to -$212.6 million; the TTM figure through Mar 2026 stood at -$212.6 million (up 13.51% YoY), while the FY2025 annual figure was -$205.0 million, up 12.7% from the prior year.
• Retained Earnings was -$212.6 million for Q1 2026 at Q32 Bio, down from -$205.0 million in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of -$5000.0 in Q1 2024 to a low of -$493.0 million in Q2 2023.
• Historically, Retained Earnings has averaged -$241.1 million across 5 years, with a median of -$234.8 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Retained Earnings tumbled 18055900.0% in 2022, then jumped 100.0% in 2024.
• A 5-year view of Retained Earnings shows it stood at -$404000.0 in 2022, then soared by 91.09% to -$36000.0 in 2023, then sank by 652161.11% to -$234.8 million in 2024, then grew by 12.7% to -$205.0 million in 2025, then dropped by 3.71% to -$212.6 million in 2026.
• The last three Retained Earnings figures came in at -$212.6 million (Q1 2026), -$205.0 million (Q4 2025), and -$255.3 million (Q2 2025), per Business Quant data.